Why a Strong Quarter Wasn't Enough to Send Shares of Pfizer Soaring

A strong quarter and earnings beat can sometimes give a stock a big boost. But when that doesn't happen, it usually means there are other factors that are weighing on a business and give investors reason for pause. After all, one good quarter is just that -- one quarter. What matters is the long run, and where the business will be in not just the next few months, but the coming years.Pfizer (NYSE: PFE) is a company that many people feel uncertain about these days. And that's likely why, although it reported a strong quarter and even increased its guidance recently, its stock hasn't been taking off.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool